Neuropharmacological Potential and Delivery Prospects of Thymoquinone for Neurological Disorders

Abstract EN

Thymoquinone (TQ) is an active ingredient isolated from Nigella sativa and has various pharmacological activities, such as protection against oxidative stress, inflammation, and infections.

In addition, it might be a potential neuropharmacological agent because it exhibits versatile potential for attenuating neurological impairments.

It features greater beneficial effects in toxin-induced neuroinflammation and neurotoxicity.

In various models of neurological disorders, it demonstrates emergent functions, including safeguarding various neurodegenerative diseases and other neurological diseases, such as stroke, schizophrenia, and epilepsy.

TQ also has potential effects in trauma mediating and chemical-, radiation-, and drug-induced central nervous system injuries.

Considering the pharmacokinetic limitations, research has concentrated on different TQ novel formulations and delivery systems.

Here, we visualize the neuropharmacological potential, challenges, and delivery prospects of TQ, specifically focusing on neurological disorders along with its chemistry, pharmacokinetics, and toxicity.